In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
Drug:  romidepsin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02596, NABTC-0303, U01CA062399, CDR0000370817, NCI-05-C-0098, NCT00085540

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: SCCC-12508, SCCC-12508, NCT01302808

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: Ro-CHOP, NCT01280526

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068031, NCI-00-C-0123, NCI-1053, 1053, NCT00020202

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 010049, 01-C-0049, NCI-01-C-0049, NCI-1312, NCT00020436, 1312, NCT00007345

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-00116, NCI-1715, 1715, NCT00042822

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00034, 12209B, CDR0000304460, N01CM62201, N01CM17102, U01CA099177, P30CA014599, UCCRC-12209B, NCI-5965, 5965, NCT00062075

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03005, NCI-5996, 0403-765, 5996, N01CM62204, AECM-0403765, NCT00066638

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02571, MAYO-MC0287, NCI-5961, CDR0000349660, 5961, NCT00077194

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: SWOG-S0336, S0336, NCT00077337

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00027, MMC 04-02-025S, CDR0000365527, N01CM62204, AECM-02025, NYWCCC-02025, 6335, NYWCCC-0402025S, NCI-6335, DFCI-04358, NCT00084682

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02785, CALGB-30304, P30CA014236, U10CA031946, NCT00086827

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01458, 04-059, N01CM62206, CDR0000396783, MSKCC-04059, NCI-6338, 6338, NCT00098813

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02641, MDA-2003-0895, N01CM17003, CDR0000404163, 6369, NCI-6369, NCT00098397

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000415355, U10CA021115, ECOG-E1603, E1603, NCT00104884

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FJ-228-0002, NCT00106418

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01037, CDR0000433042, CCCWFU 71103, 6319, U10CA081851, P30CA012197, NCT00112463

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GPI-06-0002, NCT00426764

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ROMI-ADVM-004, 2010-023040-32, NCT01353664

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-95066, GUMC-T95-0022, NCI-T95-0022D, T95-0022

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000065653, NCI-97-C-0135G, NCI-T95-0077, T95-0077, NCT00019318

22.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-00H0350, NCI-27, NCT00024180, 27

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 020205, 02-C-0205, NCT00037817

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01803, ADVL0212, U01CA097452, CDR0000269671, COG-ADVL0212, NCI-03-C-0307, NCT00053963

25.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2012-02657, MDA-2004-0674, NCI-5563, CDR0000433040, 5563, NCT00114257
1   
New Search